Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.079 | 0.2 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |